Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23279872 | 0.88 | KLKB1 (0.40) | KLKB1MAP4K1 | |
| SCHEMBL18458878 | 0.80 | KLKB1 (0.58) | KLKB1MAP4K1 | |
| SCHEMBL20616418 | 0.80 | KLKB1 (0.47) | KLKB1MAP4K1 | |
| SCHEMBL20616462 | 0.79 | KLKB1 (0.45) | KLKB1MAP4K1 | |
| SCHEMBL18458793 | 0.78 | KLKB1 (0.48) | KLKB1MAP4K1 | |
| SCHEMBL20616371 | 0.78 | KLKB1 (0.60) | KLKB1MAP4K1 | |
| SCHEMBL20282946 | 0.77 | KLKB1 (0.36) | KLKB1MAP4K1 | |
| SCHEMBL18369805 | 0.77 | KLKB1 (0.62) | KLKB1MAP4K1 | |
| SCHEMBL21657099 | 0.77 | KLKB1 (0.46) | KLKB1MAP4K1 | |
| SCHEMBL20282864 | 0.77 | KLKB1 (0.41) | KLKB1MAP4K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10308637-B2 | Therapeutic inhibitory compounds | LIFESCI PHARMACEUTICALS, INC. (BB) | 2019-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308637-B2 | Therapeutic inhibitory compounds | KLKB1, SERPINB1, SERPINE1 | KLKB1 1/4885MAP4K1 249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.